Kriya Therapeutics

Published indications, not live orders. Newest first; matching records grouped.

Latest observed Aug 6, 2026. Availability is not verified.

Buyers 0

No published buyers.

Sellers 3

Date	Price / size	Broker	Terms
Aug 6, 2026	UnpricedSize undisclosed	Setter Capital	Not specified Notes Listed in the past four days' inventory with supply available; terms were not provided.
Aug 5, 2026	UnpricedSize undisclosed	Setter Capital	Not specified Notes Supply listed in past four days of inventory.
Jul 31, 2026	UnpricedSize undisclosed	Setter Capital	Not specified Notes Listed in latest daily inventory with supply available.

Financing history

Round	Date	Raised	Pre-money	Post-money	Price / share	Investors
Series D	Aug 15, 2025	$320M	$1.4B	$1.72B	$10.34	Narya, Patient Square Capital +3 Narya Patient Square Capital Peter Thiel Premji Invest (US) T1D Fund
Series C	Jul 26, 2023	$432.04M	$437.96M	$870M	$7.24	Alumni Ventures, Anjost Investment +12 Alumni Ventures Anjost Investment Bluebird Ventures Breakthrough T1D CAM Capital Dexcel Pharma Foresite Capital James Vance Lightswitch (PTY) Narya Patient Square Capital QVT Family Office T1D Fund Transhuman Capital
Series B	Jul 14, 2021	—	—	—	—	—
Series A	Aug 17, 2020	—	—	—	—	—
Non-Equity Accelerator	Undated	—	—	—	—	—

PitchBook cached data. Investor participation is historical, not proof of current ownership. Lead labels appear only when reported. Missing details remain unspecified.

Investor participation · 16 names in the returned rounds

Investor	Reported rounds
Alumni Ventures	Series C · 2023-07-26
Anjost Investment	Series C · 2023-07-26
Bluebird Ventures	Series C · 2023-07-26
Breakthrough T1D	Series C · 2023-07-26
CAM Capital	Series C · 2023-07-26
Dexcel Pharma	Series C · 2023-07-26
Foresite Capital	Series C · 2023-07-26
James Vance	Series C · 2023-07-26
Lightswitch (PTY)	Series C · 2023-07-26
Narya	Series D · 2025-08-15 Series C · 2023-07-26
Patient Square Capital	Series D · 2025-08-15 Series C · 2023-07-26
Peter Thiel	Series D · 2025-08-15
Premji Invest (US)	Series D · 2025-08-15
QVT Family Office	Series C · 2023-07-26
T1D Fund	Series D · 2025-08-15 Series C · 2023-07-26
Transhuman Capital	Series C · 2023-07-26

Cached deal details · 5 rounds

Round / date	Type / status	Investors	Exiting investors	Stored on
Series D2025-08-15	Later Stage VCCompleted	Narya, Patient Square Capital +3 Narya Patient Square Capital Peter Thiel Premji Invest (US) T1D Fund	Not specified	2026-10-16
Series C2023-07-26	Later Stage VCCompleted	Alumni Ventures, Anjost Investment +12 Alumni Ventures Anjost Investment Bluebird Ventures Breakthrough T1D CAM Capital Dexcel Pharma Foresite Capital James Vance Lightswitch (PTY) Narya Patient Square Capital QVT Family Office T1D Fund Transhuman Capital	Not specified	2026-10-16
Series B2021-07-14	Not specifiedStatus not specified	—	Not specified	2026-10-16
Series A2020-08-17	Not specifiedStatus not specified	—	Not specified	2026-10-16
Non-Equity AcceleratorUndated	Not specifiedStatus not specified	—	Not specified	2026-10-16

Stored on is the local round-record date, not the last time PitchBook verified it. No new provider lookups run when this page is opened.

Share classes

Series	Issue price	Liq. preference	Ownership	Shares authorized
Series D	$10.34	1×	18.66%	31,014,115
Series C	$7.24	1×	36.02%	59,714,244
Series B	$6.03	1×	10%	16,585,673
Series A2	$3.98	1×	0.78%	1,291,381
Series A1	$4.97	1×	10.01%	16,598,254

Suggest a correction · Active members can send a private report for admin review.

Member view

Members see the live bid/ask book by share class, the full event history, and crossed markets across every company.